Ads
related to: modafinil and cataplexy side effects medication- XYWAV Treatment
Learn About XYWAV Treatment & See
If it's The Right Option for You.
- XYWAV Coupon Program
Eligible Patients May Pay As Little
As $5 Per Prescription. Learn More.
- XYWAV Patient Brochure
Learn Important Information
About Your XYWAV Treatment.
- XYWAV FAQ's
Get Answers to Your Questions
About Your XYWAV Treatment.
- XYWAV Treatment
Search results
Results From The WOW.Com Content Network
Common side effects of Modafinil include anxiety, insomnia, dizziness, and headache. Modafinil has potential for causing severe allergic reactions, psychiatric effects, [3] hypersensitivity, adverse interactions with prescription drugs, and misuse or abuse. [3] [8] [15] Modafinil may harm the fetus if taken during or two months prior to ...
Narcolepsy is often mistaken for depression, epilepsy, the side effects of medications, poor sleeping habits or recreational drug use, making misdiagnosis likely. [ citation needed ] While narcolepsy symptoms are often confused with depression, there is a link between the two disorders.
Common side effects include nausea, dizziness, and hallucinations. [40] A 2016 study by Leu-Semenescu et al. found sodium oxybate reduced daytime sleepiness in IH to the same degree as in patients with narcolepsy type 1, and the drug improved severe sleep inertia in 71% of the hypersomnia patients. [41]
By PIX11 Talk about a no brainer! Scientists say there's a pill that will make you smarter with almost no short-term side effects. It's not the super drug Bradley Cooper enjoys in the movie ...
It is the only drug authorised by the EMA to treat the whole disease in adults, and by the FDA to treat patients who have cataplexy with the indication to be used for combating excessive daytime sleepiness. [4] [20] This drug helps to normalise sleep architecture and inhibits the intrusion REM sleep elements like paralysis during the day. [4]
These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.